Despite recent studies demonstrating that anti-IL-5 treatment reduced airway eosinophil numbers without necessarily modifying the functionality of the remaining eosinophil cells [35], anti-IL-5 was used in a clinical setting to reduce asthma exacerbation [34]. The gene discussed is IL5; the disease is asthma.